Skip to ContentSkip to Navigation
How to find us prof. dr. J.A. (Jourik) Gietema


Cognitive Impairment in Long-Term Survivors of Testicular Cancer More Than 20 Years after Treatment

Comprehensive Assessment of Incidence, Risk Factors, and Mechanisms of Impaired Medical and Psychosocial Health Outcomes among Adolescents and Young Adults with Cancer: Protocol of the Prospective Observational COMPRAYA Cohort Study

Dose-Dependent Effect of Platinum-Based Chemotherapy on the Risk of Metachronous Contralateral Testicular Cancer

Effects of supervised exercise during adjuvant endocrine therapy in overweight or obese patients with breast cancer: The I-MOVE study

First-in-human study of the biodistribution and pharmacokinetics of 89Zr-CX-072, a novel immunopet tracer based on an anti–PD-L1 probody

Identification of 22 susceptibility loci associated with testicular germ cell tumors

Phase I study of daily and weekly regimens of the orally administered MDM2 antagonist idasanutlin in patients with advanced tumors

Predicting Outcomes in Men With Metastatic Nonseminomatous Germ Cell Tumors (NSGCT): Results From the IGCCCG Update Consortium

Survival and New Prognosticators in Metastatic Seminoma: Results From the IGCCCG-Update Consortium

(89)ZED88082A PET imaging to visualize CD8(+) T cells in patients with cancer treated with immune checkpoint inhibitor.

Read more


Samenwerken 'om iedere kankerpatiënt de nieuwste behandeling te geven'

Bijna één miljoen kankerpatiënten en het ontbreekt aan goede nazorg